Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6315-6321
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6315
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6315
Figure 1 The median progression-free survival was 30 mo and the median overall survival was 32 mo.
OS: Overall survival; PFS: Progression-free survival.
- Citation: Yan MH, Hou XB, Cai BN, Qu BL, Dai XK, Liu F. Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma. World J Clin Cases 2020; 8(24): 6315-6321
- URL: https://www.wjgnet.com/2307-8960/full/v8/i24/6315.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i24.6315